DXCM News and Press, DexCom Inc. From 04/08/23

2023-04-08 09:45:00 ET It's easy to get distracted by short-term market trends -- even if you're a seasoned investor. But avoiding emotional decisions and the temptation to try to time the market is vital for your long-term portfolio goals. Instead, consistently putting money to work in...

2023-04-06 17:02:12 ET The FDA on Thursday classified a recent product recall announced by Abbott Laboratories ( NYSE: ABT ) for millions of its FreeStyle Libre glucose monitoring systems as a Class I recall, the most serious type. The agency said that Abbott ( ABT ) began...

2023-04-06 07:45:00 ET The COVID-19 pandemic slowed business for many healthcare companies because the number of elective surgeries fell. On top of that, labor shortages for hospital staff, tightened hospital spending, and supply chain issues slowed sales of medical equipment. Howev...

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2023 financial results after market close on Thursday, April 27, 2023. Management will hold a conference call to review the company's first quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the ...

2023-04-05 09:08:00 ET The market has tested the patience of even the most seasoned of investors over the last year, and you're not alone if you've seen your portfolio struggle against the ongoing volatility. With even the most tried-and-true companies across a wide selection of industries ...

2023-04-03 05:21:52 ET Goldman Sachs is sticking with its S&P 500 ( SP500 ) ( NYSEARCA: SPY ) target of little change by year end as valuations and earnings face headwinds near term, its equity team said. "Our Long Duration basket has outperformed the Short Duration bask...

2023-03-31 08:45:00 ET Market volatility tends to affect every industry in unique ways. While there are always exceptions, healthcare has continually proven to be one of the most resilient sectors in a wide variety of market environments. If you have cash to add to stocks right now, her...

2023-03-29 16:31:59 ET Shares of Tandem Diabetes Care ( NASDAQ: TNDM ) dropped for the third straight session on Wednesday after UBS downgraded rival insulin pump maker Medtronic ( NYSE: MDT ) and preferred Abbott Laboratories ( ABT ) in the diabetes market. Down...

2023-03-29 07:45:00 ET Diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has been successful thanks to its continuous glucose monitoring (CGM) devices that allow diabetes patients to check their blood glucose levels in real time. While the growing adoption of this...

2023-03-26 12:00:27 ET The market for continuous glucose monitoring systems, where companies such as Abbott Laboratories ( ABT ) and DexCom ( NASDAQ: DXCM ) dominate, is expected to reach $31.7B by 2031, Allied Market Research said in a recent industry report. Rising dia...